Zoetis Inc  $164.18

Zoetis, Inc. is a leading animal health company that specializes in the discovery, development, manufacture, and commercialization of innovative animal health solutions. With its headquarters in Parsippany, New Jersey, Zoetis employs over 12,100 full-time employees who are committed to improving animal health and well-being around the world. The company made its initial public offering (IPO) on February 1, 2013, and has since focused on creating and commercializing a wide range of animal health products and services, including medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision livestock farming technology. Zoetis caters to eight core animal species, which includes dogs, cats, horses, cattle, swine, poultry, fish, and sheep. The company provides a range of product categories, such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives, and animal health diagnostics. Alfaxan, a product offered by Zoetis, is a popular choice among customers of both companion animals and livestock. The firm operates through two segments: the United States and International. It has a strong global presence, marketing its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia, and South America, with a reach of more than 100 countries. As a publicly traded company, the performance of Zoetis is closely monitored by investors, with its share price and market cap constantly under scrutiny. Stay up-to-date with the latest stock price today and premarket trends for Zoetis, as well as stocks share price today, to make informed investment decisions. Additionally, if you're interested in investing in Zoetis in Malaysia, you can check out the current price in Malaysia to guide your investment decisions.